Friday, 15 Dec 2017

TNF inhibitor

Datesort ascending Type Title Save
15 Feb 2017 Social RT @DrRachelTate: Biosimilars - noninferior in switch trial from IFX and CT-P13 @RheumNow @RWCSmtg https://t.co/bBAaUWHGt1
03 Feb 2017 Social infliximab 4 wks before TKA or THA did not increase risk of infection https://t.co/0PPLyNnNP5 @CCalabreseDO @HealioRheum @medpagetoday
31 Jan 2017 News Is the Jury Still Out on Triple Therapy vs. MTX + TNF inhibitor?
24 Jan 2017 Social Janssen has applied to FDA for new indications (AS, PsA) for golimumab based on GO-ALIVE, GO-VIBRANT trials https://t.co/qTZMJtWmya
12 Jan 2017 Social ARTIS #RA registry shows those initiating TNFi within 3 yrs of onset, double their odds of returning to work. https://t.co/WytSlSYRj1
04 Jan 2017 Social TNF inhibitor survival in 2687 Finnish pts - 27% discontinue TNFi in 12 mos. Worse w/ CZP & Rem, better w/ combo MTX https://t.co/13vJxWGWCs
02 Jan 2017 News Cautious Optimism for Biosimilars in Rheumatology
02 Jan 2017 Social Systematic review of >1000 IBD pts Tx w/ biosimilar CT-P13 v Remicade shows no difference in efficacy, safety, ADAbs https://t.co/BElV5shX03
21 Dec 2016 Social Janssen has filed for Simponi (golimumab) approvals for psoriatic athritis and anklylosing spondylitis https://t.co/dBv1o5WupX
13 Dec 2016 News Supreme Court Declines Biosimilar Patent Dispute
12 Dec 2016 News Random Drug Levels and Anti-Drug Antibodies Predict Rheumatoid Outcomes
05 Dec 2016 News Key Lessons from the TNF Inhibitor Head-to-Head EXXELERATE Study
01 Dec 2016 Social Good overview TB risk on TNFi (0.79%), all tx & recovered but 1 death. 76% restarted TNFi with only 1.3% TB recurr https://t.co/DQbeFmWmLX
21 Nov 2016 Social Retrosp study of Humira in 40 pts (66 eyes) w/ Behcets ocular dz showed signif less flares (200-->8.5/100PY) w/ ADA https://t.co/t8ldrYptGD
17 Nov 2016 Social RT @emartinmola: No chance for TNF blockers to improve Sjogren's syndrome https://t.co/B8HQF6QGzq
31 Oct 2016 Slide of the day 3 New TNF Inhibitor Biosimilars Approved in 2016
26 Oct 2016 Social Panel of neutrophil genes may be highly predictive of TNFi response in RA pts; CMPK2, IFIT1B, and RNASE3 https://t.co/4jjaHdgGgQ
26 Oct 2016 Social In Ireland, Pfizer has cut the price of Enbrel to match the price of Benepali - an ETN biosimilar. https://t.co/AKdp5bhHoc
24 Oct 2016 Social J&J will compete w/ price of Inflectra through a variety of innovative contracting options, discounts & rebates to payers, providers, & PBMs
19 Oct 2016 News Nor-Switch Study Shows it's Safe to Switch to a Biosimilar